A detailed history of Rosenberg Matthew Hamilton transactions in Haleon PLC stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 1,095 shares of HLN stock, worth $10,621. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,095
Previous 1,095 -0.0%
Holding current value
$10,621
Previous $9,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

SELL
$7.57 - $8.37 $2,346 - $2,594
-310 Reduced 22.06%
1,095 $8,000
Q4 2022

Jan 18, 2023

BUY
$5.96 - $8.06 $8,373 - $11,324
1,405 New
1,405 $0

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Rosenberg Matthew Hamilton Portfolio

Follow Rosenberg Matthew Hamilton and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenberg Matthew Hamilton, based on Form 13F filings with the SEC.

News

Stay updated on Rosenberg Matthew Hamilton with notifications on news.